Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Overcoming Resistance in Chronic Lymphocytic Leukemia-Maybe Less Is More?
Clin Cancer Res. 2024 Feb 1;30(3):471-473. doi: 10.1158/1078-0432.CCR-23-2872.
Clin Cancer Res. 2024.
PMID: 38055246
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.
Chong SJF, Zhu F, Dashevsky O, Mizuno R, Lai JX, Hackett L, Ryan CE, Collins MC, Iorgulescu JB, Guièze R, Penailillo J, Carrasco R, Hwang YC, Muñoz DP, Bouhaddou M, Lim YC, Wu CJ, Allan JN, Furman RR, Goh BC, Pervaiz S, Coppé JP, Mitsiades CS, Davids MS.
Chong SJF, et al.
J Clin Invest. 2023 Nov 15;133(22):e170169. doi: 10.1172/JCI170169.
J Clin Invest. 2023.
PMID: 37751299
Free PMC article.
Item in Clipboard
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors.
Sklavenitis-Pistofidis R, Lightbody ED, Reidy M, Tsuji J, Aranha MP, Heilpern-Mallory D, Huynh D, Chong SJF, Hackett L, Haradhvala NJ, Wu T, Su NK, Berrios B, Alberge JB, Dutta A, Davids MS, Papaioannou M, Getz G, Ghobrial IM, Manier S.
Sklavenitis-Pistofidis R, et al.
bioRxiv [Preprint]. 2023 Aug 3:2023.08.01.551480. doi: 10.1101/2023.08.01.551480.
bioRxiv. 2023.
PMID: 37577538
Free PMC article.
Preprint.
Item in Clipboard
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax.
Zhu F, Crombie JL, Ni W, Hoang NM, Garg S, Hackett L, Chong SJF, Collins MC, Rui L, Griffin J, Davids MS.
Zhu F, et al.
Haematologica. 2024 Jan 1;109(1):186-199. doi: 10.3324/haematol.2023.283245.
Haematologica. 2024.
PMID: 37534528
Free PMC article.
Item in Clipboard
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Penter L, Liu Y, Wolff JO, Yang L, Taing L, Jhaveri A, Southard J, Patel M, Cullen NM, Pfaff KL, Cieri N, Oliveira G, Kim-Schulze S, Ranasinghe S, Leonard R, Robertson T, Morgan EA, Chen HX, Song MH, Thurin M, Li S, Rodig SJ, Cibulskis C, Gabriel S, Bachireddy P, Ritz J, Streicher H, Neuberg DS, Hodi FS, Davids MS, Gnjatic S, Livak KJ, Altreuter J, Michor F, Soiffer RJ, Garcia JS, Wu CJ.
Penter L, et al.
Blood. 2023 Apr 13;141(15):1817-1830. doi: 10.1182/blood.2022018246.
Blood. 2023.
PMID: 36706355
Free PMC article.
Item in Clipboard
Cite
Cite